Greater Uppsala Metropolitan Area
Kontaktinformation
1 tn följare
Fler än 500 kontakter
Greater Uppsala Metropolitan Area
Kontaktinformation
1 tn följare
Fler än 500 kontakter
Aktivitet
-
Åh, en gullig liten EU-förordning på 80 sidor. Jag gillar fortfarande att få tumma på vanligt papper/vända blad när jag läser. Kanske beror det…
Åh, en gullig liten EU-förordning på 80 sidor. Jag gillar fortfarande att få tumma på vanligt papper/vända blad när jag läser. Kanske beror det…
Gillat av Margareth Jorvid
-
Great news!! 🎉🎉 ISCT, International Society for Cell & Gene Therapy are offering up to 60% discount off registration for the #European meeting in…
Great news!! 🎉🎉 ISCT, International Society for Cell & Gene Therapy are offering up to 60% discount off registration for the #European meeting in…
Gillat av Margareth Jorvid
-
Another first for ISCT, International Society for Cell & Gene Therapy #Europe meetings! #Innovation zones! If you are a #startup working in the area…
Another first for ISCT, International Society for Cell & Gene Therapy #Europe meetings! #Innovation zones! If you are a #startup working in the area…
Gillat av Margareth Jorvid
Erfarenhet och utbildning
-
Methra Uppsala AB
Se Margareths fullständiga erfarenhet
Genom att klicka på Fortsätt för att gå med eller logga in samtycker du till LinkedIns användaravtal, sekretesspolicy och cookiepolicy.
Fler aktiviteter efter Margareth
-
The #TOPRA #Symposium is #Europe’s premier #conference for #healthcare #regulatoryaffairs. Natasha Bankowski is a member of the #MedicalDevices /…
The #TOPRA #Symposium is #Europe’s premier #conference for #healthcare #regulatoryaffairs. Natasha Bankowski is a member of the #MedicalDevices /…
Gillat av Margareth Jorvid
-
Exciting times in Alzheimer's research! 🧠 The authorization of several drugs for treating Alzheimer's is a positive step forward for the field. At…
Exciting times in Alzheimer's research! 🧠 The authorization of several drugs for treating Alzheimer's is a positive step forward for the field. At…
Gillat av Margareth Jorvid
-
Last but not least, the final drug in our pipeline series of posts is ELC-100, an oncolytic virus known as AdVince currently in a phase I/II study…
Last but not least, the final drug in our pipeline series of posts is ELC-100, an oncolytic virus known as AdVince currently in a phase I/II study…
Gillat av Margareth Jorvid
-
As many of you know, the ISCT community is truly something special. Our global, expert-guided, and translation-focused community thrives because of…
As many of you know, the ISCT community is truly something special. Our global, expert-guided, and translation-focused community thrives because of…
Gillat av Margareth Jorvid
-
We are now inviting nominations for TOPRA President Elect and two Board Director positions for 2025. Stand for #election for your chance to…
We are now inviting nominations for TOPRA President Elect and two Board Director positions for 2025. Stand for #election for your chance to…
Gillat av Margareth Jorvid
-
Five years ago, after being part of Thermo Fisher Scientific for 20 years, I made the decision to seek new opportunities, outside of my comfort zone.…
Five years ago, after being part of Thermo Fisher Scientific for 20 years, I made the decision to seek new opportunities, outside of my comfort zone.…
Gillat av Margareth Jorvid
-
My Moberg har utsetts till ny direktör för verksamhetsområdet tillstånd på Läkemedelsverket. 🗨️ –Det är glädjande att få välkomna My som direktör…
My Moberg har utsetts till ny direktör för verksamhetsområdet tillstånd på Läkemedelsverket. 🗨️ –Det är glädjande att få välkomna My som direktör…
Gillat av Margareth Jorvid
-
I am so honoured being elected as chair for the Pharmacovigilance Risk Assessment Committee for the coming 3 years, taking over from Dr Sabine…
I am so honoured being elected as chair for the Pharmacovigilance Risk Assessment Committee for the coming 3 years, taking over from Dr Sabine…
Gillat av Margareth Jorvid
-
The third drug we are spotlighting in our pipeline series is ELC-201, our next-generation oncolytic virus immunotherapy. ELC-201 is based on a…
The third drug we are spotlighting in our pipeline series is ELC-201, our next-generation oncolytic virus immunotherapy. ELC-201 is based on a…
Gillat av Margareth Jorvid
-
ISCT joins 30+ organizations urging all of those involved in the new EU Joint Clinical Assessment (JCA) to recognize and use all types of available…
ISCT joins 30+ organizations urging all of those involved in the new EU Joint Clinical Assessment (JCA) to recognize and use all types of available…
Gillat av Margareth Jorvid
-
Fantastiska nyheter för life science-sektorn i Sverige! Vi, tre av landets främsta innovationsinfrastrukturer, NorthX Biologics, Testa Center och…
Fantastiska nyheter för life science-sektorn i Sverige! Vi, tre av landets främsta innovationsinfrastrukturer, NorthX Biologics, Testa Center och…
Gillat av Margareth Jorvid
-
Får jag slå ett slag för dotterns debut som författare!
Får jag slå ett slag för dotterns debut som författare!
Gillat av Margareth Jorvid
-
📣 EMA’s safety Committee, the #PRAC, just elected Ulla Wändel Liminga from the Swedish Medical Products Agency (Medical Products Agency…
📣 EMA’s safety Committee, the #PRAC, just elected Ulla Wändel Liminga from the Swedish Medical Products Agency (Medical Products Agency…
Gillat av Margareth Jorvid
-
Thanks American Physiological Society for selecting the MOA and preclinical PoC for our #ILP100 #Oral as a #APSselect publication 😀 In case You…
Thanks American Physiological Society for selecting the MOA and preclinical PoC for our #ILP100 #Oral as a #APSselect publication 😀 In case You…
Gillat av Margareth Jorvid
-
Next up in our pipeline series is ELC-401, a CAR T-cell therapy for the initial treatment of brain tumors, armed via our iTANK-platform…
Next up in our pipeline series is ELC-401, a CAR T-cell therapy for the initial treatment of brain tumors, armed via our iTANK-platform…
Gillat av Margareth Jorvid
-
Excited to share yet another important milestone in our phase 1b study in Alzheimer patients. Great work by the Alzinova AB team and Clinical…
Excited to share yet another important milestone in our phase 1b study in Alzheimer patients. Great work by the Alzinova AB team and Clinical…
Gillat av Margareth Jorvid